AGL - ANGLE plc Stock Price, News & Analysis

GBX 43.50 0.50 (1.16 %)
(As of 11/24/2017 04:00 PM ET)
Previous CloseGBX 43.50
Today's RangeGBX 43.50 - GBX 41.60
52-Week RangeGBX 32.27 - GBX 80
Volume90,577 shs
Average Volume174,013 shs
Market Capitalization£30.80 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About ANGLE plc (LON:AGL)

ANGLE plc logoANGLE plc is a holding company. The Company's principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The resulting liquid biopsy (blood test) enables the detection and investigation of mutations in the patient's cancer for personalized cancer care. The harvested CTCs have a range of applications, including diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring.

Industry, Sector and Symbol

Industry Bio Therapeutic Drugs
Sub-IndustryN/A
SectorHealthcare
SymbolLON:AGL
CUSIPN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSGBX (0.09)
Net IncomeN/A
Net Margins-1,326.88%
Return on Equity-61.37%
Return on Assets-60.16%

Miscellaneous

EmployeesN/A
Outstanding Shares112,510,000

Frequently Asked Questions for ANGLE plc (LON:AGL)

What is ANGLE plc's stock symbol?

ANGLE plc trades on the London Stock Exchange (LON) under the ticker symbol "AGL."

Where is ANGLE plc's stock going? Where will ANGLE plc's stock price be in 2017?

1 Wall Street analysts have issued twelve-month target prices for ANGLE plc's shares. Their predictions range from GBX 108 to GBX 108. On average, they expect ANGLE plc's stock price to reach GBX 108 in the next twelve months. View Analyst Ratings for ANGLE plc.

Who are some of ANGLE plc's key competitors?

Who are ANGLE plc's key executives?

ANGLE plc's management team includes the folowing people:

  • Andrew D. W. Newland, Chief Executive, Executive Director
  • Ian F. Griffiths, Finance Director, Company Secretary, Executive Director
  • Garth R. Selvey, Non-Executive Chairman of the Board (Age 59)
  • Brian Howlett, Non-Executive Director
  • David W. Quysner CBE, Non-Executive Independent Director

How do I buy ANGLE plc stock?

Shares of ANGLE plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is ANGLE plc's stock price today?

One share of ANGLE plc stock can currently be purchased for approximately GBX 43.50.

How big of a company is ANGLE plc?

ANGLE plc has a market capitalization of £30.80 million.

How can I contact ANGLE plc?

ANGLE plc's mailing address is The Surrey Research Park 3 Frederick Sanger Road, GUILDFORD, GU2 7YD, United Kingdom. The company can be reached via phone at +44-1483-685830.


MarketBeat Community Rating for ANGLE plc (AGL)

Community Ranking:  1.3 out of 5 (star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  98 (Vote Underperform)
Total Votes:  132
MarketBeat's community ratings are surveys of what our community members think about ANGLE plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for ANGLE plc (LON:AGL)

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.002.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 108GBX 108N/AN/A

Consensus Price Target History for ANGLE plc (LON:AGL)

Price Target History for ANGLE plc (LON:AGL)

Analysts' Ratings History for ANGLE plc (LON:AGL)

Show:
DateFirmActionRatingPrice TargetDetails
11/21/2017FinnCapReiterated RatingCorporateGBX 108View Rating Details
7/5/2017Beaufort SecuritiesReiterated RatingSpeculative BuyView Rating Details
(Data available from 11/24/2015 forward)

Earnings

Earnings History for ANGLE plc (LON:AGL)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for ANGLE plc (LON:AGL)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for ANGLE plc (LON:AGL)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for ANGLE plc (LON AGL)

Insider Trades by Quarter for ANGLE plc (LON:AGL)

Insider Trades by Quarter for ANGLE plc (LON AGL)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/26/2016Andrew D NewlandInsiderBuy1,350,000GBX 57£769,500
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ANGLE plc (LON AGL)

Source:
DateHeadline
COLLABORATION WITH PHILIPS IN BREAST AND RECTAL CANCERCOLLABORATION WITH PHILIPS IN BREAST AND RECTAL CANCER
www.streetinsider.com - November 24 at 3:22 PM
Angle Reveals Collaboration With Philips For Liquid Biopsy SolutionAngle Reveals Collaboration With Philips For Liquid Biopsy Solution
www.nasdaq.com - November 24 at 3:22 PM
ANGLE plc (AGL) Stock Rating Reaffirmed by FinnCapANGLE plc (AGL) Stock Rating Reaffirmed by FinnCap
www.americanbankingnews.com - November 23 at 11:20 PM
PHILIPS COLLABORATION IN BREAST AND RECTAL CANCER - London South East (blog)PHILIPS COLLABORATION IN BREAST AND RECTAL CANCER - London South East (blog)
www.lse.co.uk - November 23 at 3:25 PM
ANGLE plc: Result of AGM LocationANGLE plc: Result of AGM Location
www.streetinsider.com - October 31 at 4:46 PM
ANGLE Plc :AGL-GB: Earnings Analysis: 2017 By the Numbers : October 12, 2017ANGLE Plc :AGL-GB: Earnings Analysis: 2017 By the Numbers : October 12, 2017
finance.yahoo.com - October 12 at 9:21 PM
ANGLE Plc :AGL-GB: Earnings Analysis: For the six months ended April 30, 2017 : October 12, 2017ANGLE Plc :AGL-GB: Earnings Analysis: For the six months ended April 30, 2017 : October 12, 2017
finance.yahoo.com - October 12 at 9:21 PM
ANGLE plc Announces Parsortix System Central to Potential New Analytical Protocol for Identifying Drugs That May Arrest MetastasisANGLE plc Announces Parsortix System Central to Potential New Analytical Protocol for Identifying Drugs That May Arrest Metastasis
www.finanznachrichten.de - October 9 at 4:41 PM
Angle PLC: Results of FundraisingAngle PLC: Results of Fundraising
www.finanznachrichten.de - October 5 at 1:02 PM
Angle PLC: Exclusive Worldwide Option Over Megakaryocyte Intellectual PropertyAngle PLC: Exclusive Worldwide Option Over Megakaryocyte Intellectual Property
finance.yahoo.com - September 13 at 4:41 PM
Co-Marketing Partnership with QIAGENCo-Marketing Partnership with QIAGEN
www.lse.co.uk - September 11 at 4:24 PM
Why ANGLE Plc (AIM:AGL) Could Be A BuyWhy ANGLE Plc (AIM:AGL) Could Be A Buy
finance.yahoo.com - September 9 at 3:27 PM
New Research with Parsortix - London South East (registration) (blog)New Research with Parsortix - London South East (registration) (blog)
www.lse.co.uk - September 4 at 9:15 PM
Angle PLC Announces New Research With Parsortix Demonstrates Ability to Identify Key Proteins Involved in Breast ... - BenzingaAngle PLC Announces New Research With Parsortix Demonstrates Ability to Identify Key Proteins Involved in Breast ... - Benzinga
www.benzinga.com - September 4 at 9:15 PM
Angle PLC: Preliminary ResultsAngle PLC: Preliminary Results
feeds.benzinga.com - July 27 at 2:59 AM
Preclinical Study Using Parsortix Presented at Tumor Models Boston SummitPreclinical Study Using Parsortix Presented at Tumor Models Boston Summit
finance.yahoo.com - July 20 at 4:33 PM
ANGLE plc (AGL) Set to Announce Earnings on ThursdayANGLE plc (AGL) Set to Announce Earnings on Thursday
www.americanbankingnews.com - July 20 at 1:50 AM
SUCCESS WITH PARSORTIX IN COLORECTAL CANCER - London South East (registration) (blog)SUCCESS WITH PARSORTIX IN COLORECTAL CANCER - London South East (registration) (blog)
www.lse.co.uk - June 6 at 10:32 AM
ANGLE Reports Positive Results For Parsortix System In Colorectal CancerANGLE Reports Positive Results For Parsortix System In Colorectal Cancer
www.rttnews.com - June 5 at 1:36 PM
Half Year 2017 Angle PLC Earnings Release - Before Market OpenHalf Year 2017 Angle PLC Earnings Release - Before Market Open
biz.yahoo.com - January 26 at 3:36 PM
Could this small cap double after posting a £2.7m LOSS?Could this small cap double after posting a £2.7m LOSS?
uk.finance.yahoo.com - January 26 at 3:36 PM
ANGLE plc: Issue of Share OptionsANGLE plc: Issue of Share Options
www.marketwatch.com - November 28 at 2:45 PM
ANGLE plc: Result of GMANGLE plc: Result of GM
www.streetinsider.com - November 24 at 3:01 PM
Global Lender Equities First Holdings Returns Shares of ANGLE plc and Concludes Transaction in the United KingdomGlobal Lender Equities First Holdings Returns Shares of ANGLE plc and Concludes Transaction in the United Kingdom
www.streetinsider.com - October 28 at 12:58 PM
MD Anderson Cancer Center Research Demonstrates Clinical Applicability of ANGLE plc’s ‘Blood Biopsy’ TechnologyMD Anderson Cancer Center Research Demonstrates Clinical Applicability of ANGLE plc’s ‘Blood Biopsy’ Technology
uk.finance.yahoo.com - August 2 at 8:08 AM
ANGLE plc: Use of Parsortix in GANNET53 Drug TrialANGLE plc: Use of Parsortix in GANNET53 Drug Trial
www.streetinsider.com - July 28 at 11:58 AM
Full Year 2016 Angle PLC Earnings Release - Before Market OpenFull Year 2016 Angle PLC Earnings Release - Before Market Open
biz.yahoo.com - July 28 at 7:07 AM

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

ANGLE plc (LON AGL) Chart for Friday, November, 24, 2017
Loading chart…

This page was last updated on 11/24/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.